Mandara Biopharma Inc. is a privately held U.S.-based biopharmaceutical company focused on novel therapies to treat CNS diseases. Their product pipeline includes new therapies for Alzheimer’s Agitation (2027 scheduled launch), Traumatic Brain Injury (2029) and PTSD (2030). Learn more at www.mandarab... Read more
This company has no teams yet
This company has no offices yet